<?xml version="1.0" encoding="UTF-8"?>
<p>All the samples from patient suspected of having dengue fever (as per WHO guidelines) referred to VRDL from the medical facilities (public or private) of the state and also the samples referred directly by state health authorities for suspected dengue cases were all included for the study. The samples consisted blood samples of both inpatient and outpatient collected during acute phase along with a case report form detailing demographic, clinical, and laboratory characteristics. Serum was separated as soon as possible and refrigerated (2–8 °C) or stored frozen (≤−20 °C), if not tested within 48hrs.Samples obtained within 5 days of onset of fever were qualitatively tested for presence of dengue viral NS1 antigen using the dengue NS1 antigen ELISA (Microlisa J. Mitra &amp; Co. Pvt. Ltd.) supplied by NVBDCP (National Vector Borne Disease Control Program), Manipur where as samples of patients with fever of more than five days duration at time of collection were tested for the presence of anti-dengue IgM antibodies using MAC ELISA NIV (National Institute of Virology), Pune.</p>
